These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 19003369)
1. The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses. Merten OW; Kallel H; Manuguerra JC; Tardy-Panit M; Crainic R; Delpeyroux F; Van der Werf S; Perrin P Cytotechnology; 1999 Jul; 30(1-3):191-201. PubMed ID: 19003369 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines. Merten OW; Kierulff JV; Castignolles N; Perrin P Cytotechnology; 1994; 14(1):47-59. PubMed ID: 7765112 [TBL] [Abstract][Full Text] [Related]
3. An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system. Perrin P; Madhusudana S; Gontier-Jallet C; Petres S; Tordo N; Merten OW Vaccine; 1995 Sep; 13(13):1244-50. PubMed ID: 8578811 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the serum-free medium MDSS2 for the production of poliovirus on vero cells in bioreactors. Merten OW; Wu R; Couvé E; Crainic R Cytotechnology; 1997 Nov; 25(1-3):35-44. PubMed ID: 22358877 [TBL] [Abstract][Full Text] [Related]
5. A simple serum-free freezing medium for serum-free cultured cells. Merten OW; Petres S; Couvé E Biologicals; 1995 Jun; 23(2):185-9. PubMed ID: 7546662 [TBL] [Abstract][Full Text] [Related]
6. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Rourou S; van der Ark A; van der Velden T; Kallel H Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281 [TBL] [Abstract][Full Text] [Related]
7. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells. Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017 [TBL] [Abstract][Full Text] [Related]
8. An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines. Rourou S; Ben Ayed Y; Trabelsi K; Majoul S; Kallel H Vaccine; 2014 May; 32(24):2767-9. PubMed ID: 24583007 [TBL] [Abstract][Full Text] [Related]
9. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media. Genzel Y; Olmer RM; Schäfer B; Reichl U Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022 [TBL] [Abstract][Full Text] [Related]
10. Production of influenza virus in serum-free mammalian cell cultures. Merten OW; Manuguerra JC; Hannoun C; van der Werf S Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957 [TBL] [Abstract][Full Text] [Related]
11. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. Genzel Y; Fischer M; Reichl U Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544 [TBL] [Abstract][Full Text] [Related]
12. Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media. Merten OW Dev Biol (Basel); 2002; 111():233-57. PubMed ID: 12678248 [TBL] [Abstract][Full Text] [Related]
13. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor. Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697 [TBL] [Abstract][Full Text] [Related]
14. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium. Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647 [TBL] [Abstract][Full Text] [Related]
15. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media. Rourou S; Ben Zakkour M; Kallel H Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054 [TBL] [Abstract][Full Text] [Related]
16. Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium. Hu AY; Tseng YF; Weng TC; Liao CC; Wu J; Chou AH; Chao HJ; Gu A; Chen J; Lin SC; Hsiao CH; Wu SC; Chong P PLoS One; 2011 Jan; 6(1):e14578. PubMed ID: 21283675 [TBL] [Abstract][Full Text] [Related]
17. Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium. Mattos DA; Silva MV; Gaspar LP; Castilho LR Vaccine; 2015 Aug; 33(35):4288-91. PubMed ID: 25930117 [TBL] [Abstract][Full Text] [Related]
18. Higher production of rabies virus in serum-free medium cell cultures on microcarriers. Frazzati-Gallina NM; Paoli RL; Mourão-Fuches RM; Jorge SA; Pereira CA J Biotechnol; 2001 Dec; 92(1):67-72. PubMed ID: 11604174 [TBL] [Abstract][Full Text] [Related]
19. Production of canine adenovirus type 2 in serum-free suspension cultures of MDCK cells. Castro R; Fernandes P; Laske T; Sousa MF; Genzel Y; Scharfenberg K; Alves PM; Coroadinha AS Appl Microbiol Biotechnol; 2015 Sep; 99(17):7059-68. PubMed ID: 25994255 [TBL] [Abstract][Full Text] [Related]
20. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process. George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]